Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-24

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to test a new way to diagnose and track treatment of spine infections caused by the bacteria Staphylococcus aureus.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MSSA and MRSA Screening in Patients Undergoing Elective TJA: the Benefits of Next-generation Sequencing

NCT04574752

Staphylococcus Aureus Next Generation Sequencing Total Joint Arthroplasty

UNKNOWN

Modeling Host-Pathogen Interaction Using Lymphoid Organoids

NCT06479837

Staphylococcal Infections

RECRUITING

Obtaining and Storing Human Blood, Urine, and Fecal Samples for Spirochete-Related Epidemiological Research

NCT01089153

The Samples Will be Studied in Order to Attempt to Better Understand the Occurrence of Blood, Feces and Urine Borne Spirochaetes

COMPLETED

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

NCT01184339

Bacteremia

COMPLETED

Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma

NCT02842710

Emergencies

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ongoing Staphylococcus aureus (S. aureus) infections of the spine associated with orthopedic hardware implants elicit prominent immune responses against a repertoire of proteins characteristic of the invading pathogen. Antibodies specific for these antigens can be measured in the serum or in a novel sample created by culturing circulating Antibody Secreting Cells (ASC) in vitro where they create an analytic fluid called here "medium enriched for newly synthesized antibodies" (MENSA). The hypothesis of this study addresses three essential attributes of this analytic approach that can yield both a valuable tool for research on spinal infections and in the future, this can be developed a clinical tool for diagnosis and monitoring of therapeutic success in patients. By measuring the emergence of these signature antibodies in the serum and/or MENSA, the goals of this study are: 1) To differentiate between patients with an ongoing S. aureus infections, not just "general infection, in the spine using only blood samples; 2) To track the success (or failure) of therapeutic interventions; and 3) to distinguish spinal infections from S. aureus infections in other sites by the repertoire of antibodies that are elicited.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Staphylococcus Aureus Infection Surgical Site Infection Orthopedic Procedures Spine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spine implant associated infection cohort

Adult patients undergoing revision spine surgeries with suspected infection of previous instrumentation.

Medium enriched for newly synthesized antibodies in spine infection

Intervention Type DIAGNOSTIC_TEST

Medium enriched for newly synthesized antibodies titers in patients with Staphylococcus aureus infections of orthopedic spine implants at baseline and in the post operative period

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medium enriched for newly synthesized antibodies in spine infection

Medium enriched for newly synthesized antibodies titers in patients with Staphylococcus aureus infections of orthopedic spine implants at baseline and in the post operative period

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with known or suspected spinal infections associated with spinal orthopedic implant(s);
* patients over 18 years of age and younger than 85;
* patients undergoing spinal revision surgery.

Exclusion Criteria

* Diagnosed as immuno-compromised or immuno-suppressed based on medication use;
* On-going or previously diagnosed musculoskeletal infections associated non-spine hardware (e.g., prosthetic hip, prosthetic knee, prosthetic shoulder);
* Current diabetic foot ulcer/infection;
* Patients undergoing cancer treatment (including radiation and chemotherapies);
* Pregnancy;
* Absence of a spleen;
* Over the age of 85 or under the age of 18.
* Weigh less than 110 pounds, or for which it would otherwise be unsafe for them to undergo a blood draw.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No